CMS backed away Thursday (Nov. 6) from draft guidance issued at the end of September laying out how Part D sponsors starting in 2016 should report price concessions negotiated with pharmacies -- a little-notice technical guidance that was praised by pharmacies but lambasted by pharmaceutical benefit managers as a dramatic Part D shift that violated the “non-interference clause” of the Social Security Act. In a Nov. 6 memo to Part D sponsors the agency says it will look further into...